What is it?
Common asparagus, not shatavari
1This profile is for Asparagus officinalis: common/garden asparagus, asparagus stem powder, and ETAS-style stem extract. It should not be merged with shatavari (Asparagus racemosus), which is a different species with a different traditional and research profile.
Human evidence is limited and heterogeneous
2A 2026 systematic review found modest signals across sleep, stress and cognitive outcomes. Preparations and participants varied, studies were small, and some authors had manufacturer affiliations. This supports cautious, preparation-specific interpretation rather than a general nootropic claim.
Stress and fatigue signal is ETAS-specific
3A small placebo-controlled crossover trial in healthy volunteers reported improvements in some fatigue ratings and arithmetic-task performance under stress with ETAS. Serum and salivary cortisol and plasma catecholamines did not change. The findings do not establish broad cognitive enhancement, and several authors worked for the manufacturer.
Sleep and work engagement: uncontrolled findings
4A before-and-after study in shift-working nurses reported improvements in sleep, fatigue and work engagement, but no significant improvement in impaired work functioning. Without a placebo comparison, expectations and other changes cannot be excluded.
Metabolic studies do not equal brain claims
6A 12-week exploratory trial in 44 overweight or obese adults found differences in some metabolic markers with asparagus powder. Several other outcomes, including LDL cholesterol and insulin-resistance measures, did not differ significantly between groups. These endpoints do not establish cognitive benefits.
Names, aliases and forms
Mechanisms of action
Polyphenols, saponins and ETAS markers are mechanism context
2Polyphenols and saponins are plant-compound classes discussed in asparagus research. Proposed stress-response and antioxidant mechanisms remain supporting context; a biochemical pathway is not proof that a generic powder improves cognition.
Potential effects and evidence map
A 2026 systematic review reports modest sleep, stress and cognitive signals across small, heterogeneous adult studies. The evidence is limited by differences in preparations, populations and outcomes, with manufacturer involvement in parts of the literature. Findings from ETAS stem extracts do not establish equivalent benefits for generic asparagus powders or ordinary food servings.
ETAS has limited human evidence for stress-response support, but the evidence is small and product-specific.
Small studies report sleep-quality signals with asparagus stem preparations; results are not transferable to every powder.
Mood and fatigue signals are limited and preparation-specific, with small ETAS trials and uncontrolled shift-worker observations.
One small ETAS trial reported better arithmetic-task performance under stress after repeated use; dependable acute focus benefits remain unestablished.
Polyphenol, saponin, antioxidant, and preclinical ETAS mechanisms are plausible but not proof of brain-health outcomes in humans.
Typical dosages and timing
The ETAS stress trial used 150 mg/day of its specific preparation for 28 days. This amount cannot be converted into a dose for generic asparagus powder, food servings or a different extract. No single evidence-based dosage range spans these products.
Timing & effect horizon
The 28-day timing fact is the duration of the ETAS stress study, not effect onset or the length of one dose. Reliable onset, The time for blood levels to fall by half during the final elimination phase.Source, single-dose duration and an optimal cycling schedule are not established for the range of asparagus products.
Safety, side effects and risk profile
Short ETAS safety research found no severe adverse effects; tolerability can differ with powder composition and concentration.
Metabolic-marker studies do not establish a clinically important blood-pressure interaction.
Dedicated clinical interaction data for concentrated asparagus products are limited. General supplement-medication review remains relevant.
Short healthy-volunteer studies do not establish safety in people with significant kidney or liver disease.
The adult studies cited here do not establish pregnancy or lactation safety for concentrated products.
The main risk is overgeneralizing a small, heterogeneous evidence base across very different asparagus products.
A placebo-controlled trial analyzed 46 healthy adults taking ETAS50 or placebo for 28 days and reported no severe adverse effects. This supports a minimal base-risk rating for ordinary short-term healthy-adult use, while it does not establish long-term safety or cover every powder, extract or special population.
People with known asparagus allergy are outside the healthy-adult base-risk assessment. In sensitized patients, reactions after ingestion can be serious, including anaphylaxis. An allergy-clinic case series documents this hazard but cannot estimate how often it occurs among ordinary users; processing does not establish that a supplement is suitable for someone with asparagus allergy.
Interactions and cautions
The cited studies do not establish clinically important asparagus-specific drug interactions. Medication use, pregnancy or lactation, significant illness and prolonged concentrated-extract use fall outside the healthy-adult base-risk assessment; the available trials do not resolve these situations.
Legal and regulatory status
As of 18 October 2026, in the United States, FDA does not approve dietary supplements before marketing. A listed asparagus product is therefore not evidence of FDA approval of its efficacy or safety. This general U.S. framework does not establish the status of a particular extract in the EU, UK or another market.
Practical buying and quality notes
- Prefer labels that specify Asparagus officinalis, plant part, extract type, dose per serving, standardization if any, batch testing, and whether the product is ETAS or a generic asparagus powder. Do not apply ETAS study findings to low-dose blends without matching evidence.3
- Use price per gram only when species, plant part and extract specification are comparable. A missing or zero recorded quantity can create a misleading zero unit price: check package size and checkout price at the retailer. Generic extract powder cannot be ranked against ETAS by weight alone, and a blend total does not disclose its asparagus dose.
FAQ
Is Asparagus a nootropic?
2Not in the strong sense. It has limited, preparation-specific human sleep and stress evidence, but no dependable acute focus, memory or mental-energy effect is established.
What dose of Asparagus is studied?
3There is no single established dose for all asparagus supplements. The dosage section describes one ETAS trial; powder studies use different preparations and gram-scale amounts. Match the preparation before interpreting study quantities.
Is ETAS the same as asparagus powder?
3No. ETAS is a branded, enzyme-processed Asparagus officinalis stem preparation. A generic powder or blend can differ in plant part, processing and composition; its total weight does not establish an equivalent amount of the studied ingredient.
How long does Asparagus take, and should it be cycled?
2Study length is not a validated onset or cycle. Repeated-use studies do not establish when an individual will notice an effect, how long it lasts after a dose, or whether scheduled breaks improve outcomes.
References
- NCBI Taxonomy. Asparagus officinalis, Taxonomy ID 4686. Accessed 2026-06-30.
- The Effect of Asparagus Stem Consumption on Health Outcomes in Adults: A Systematic Review. British Journal of Nutrition. 2026.
- Effect of Enzyme-Treated Asparagus Extract (ETAS) on Psychological Stress in Healthy Individuals. Journal of Nutritional Science and Vitaminology. 2016;62(3):198-205.
- Sakai S et al. Improved Sleep Quality and Work Performance Among Shift Workers Consuming a Foods with Function Claims Containing Asparagus Extract. Journal of UOEH. 2021;43(1):15-23.
- Improvement of Blood Pressure, Glucose Metabolism, and Lipid Profile by the Intake of Powdered Asparagus Bottom-stems and Cladophylls. Journal of Traditional and Complementary Medicine. 2013;3(4):250-255.
- Effects of Asparagus Powder Supplementation on Glycemic Control, Lipid Profile, and Oxidative Stress in Overweight and Obese Adults: An Exploratory Randomized Controlled Trial. Life. 2025.
- A Standardized Extract of Asparagus officinalis Stem (ETAS) Ameliorates Cognitive Impairment, Inhibits Amyloid Beta Deposition via BACE-1 and Normalizes Circadian Rhythm Signaling via MT1 and MT2. Nutrients. 2019;11(7):1631.
- Yasueda A et al. Safety Evaluation of a Standardised Extract of Asparagus officinalis Stem in Healthy Volunteers: a Double-Blind and Randomised Controlled Trial. Journal of Herbal Medicine. 2023;42:100789.
- FDA. Questions and Answers on Dietary Supplements. Accessed 2026-10-18.
- Tabar AI et al. Diversity of asparagus allergy: clinical and immunological features. Clinical and Experimental Allergy. 2004;34(1):131-136.